Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting with Bed Bath Beyond South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Disputes Billionaire Rotates from Cloud to AI Strategic Shift or Market Overreaction Spotify Surges on AI Deal with Universal Music and LongTerm Revenue Guidance Gentell CEO Navigates Oil Price Volatility Amid Strait of Hormuz Crisis Treasury Yield Surge Challenges RiskFree Asset Assumptions as Geopolitical Tensions and Inflation Reshape Fed Policy Outlook WATT Q1 2026 Earnings NarrowerthanExpected Loss Reflects Effective Cost Control QuinStreet QNST Q1 2026 Earnings EPS Misses Estimates Slightly Stock Gains on Operational Resilience Mesabi Trust Q1 2026 Earnings Royalty Income Delivers 021 Per Unit Amid Quiet Quarter JSPR Q1 2026 Earnings Stunning EPS Beat Highlights Cost Discipline as PreRevenue Biotech Advances Pipeline Turn Therapeutics Inc TTRX Q1 2026 Earnings Narrow EPS Miss Overshadowed by Operational Progress Addus HomeCare ADUS Q1 2026 Earnings Earnings Beat Despite Soft Stock Reaction Toll Brothers TOL Holds Sluggish as Sellers Test Key Support Zone Gulfport Energy GPOR Slips Over 2 as Resistance Holds Key Support Levels in Focus Sypris Solutions SYPR Edges Higher as Stock Tests Key Technical Levels Corvex Inc MOVE Drops 317 as Resistance Holds Key Support in Focus Templeton Emerging Markets Income Fund TEI Gains 104 as Support Holds Above 600 Reliance Industries Invests Billions in New Energy FMCG and Digital Businesses in FY26 BioCardia Inc BCDA Q1 2026 Earnings Misses EPS Estimates Amid No Revenue PMGC Holdings Inc ELAB Edges Lower as Stock Holds Above Key Support Level Tillys Inc TLYS Recovers to 434 Potential Support Test as Retail Sector Shows Mixed Signals K2 Capital Acquisition Corporation Rights KTWOR Hold Steady at 022 Amid Low Volume MainStreet Bancshares Inc MNSB Edges Lower Amid Low Volume Key Levels Hold Professional Diversity Network IPDN Gains 2 as Stock Nears Key Resistance Level Elanco Animal Health ELAN Gains Ground After Positive Session LFMDP Preferred Stock Edges Higher Amid Steady Preferred Market Sentiment Definium Therapeutics DFTX Surges 341 as Volume Picks Up Testing Key Resistance